|
시장보고서
상품코드
2075288
랩온어칩 및 마이크로어레이(바이오칩) 시장 : 유형별, 제품 유형별, 용도별, 최종사용자별 및 지역별-Lab-on-a-chip and Microarrays (Biochip) Market, By Type, By Product, By Application, By End User, and By Geography - |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
랩온어칩 및 마이크로어레이(바이오칩) 시장은 2026년에 252억 2,980만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 617억 1,140만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 13.6%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 252억 2,980만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 13.60% | 2033년 시장 규모 예측 : | 617억 1,140만 달러 |
바이오칩이란 고체 기판 위에 배치된 미세한 검사 부위(마이크로어레이)의 집합체로, 다수의 검사를 동시에 수행함으로써 높은 처리량과 처리 속도를 실현합니다. 바이오칩은 수천 가지의 생물학적 반응을 수행할 수 있습니다.
시장 역학 :
만성질환의 부담 증가, 현장 진단(Point-of-Care) 검사에 대한 수요 증가, 암 연구 분야에서의 단백질체학 및 유전체학 응용 확대, 맞춤형 의료의 보급, 그리고 미세유체 소재에 대한 수요 증가가 전 세계 랩-온-어-칩 및 마이크로어레이(바이오칩) 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어 2022년 10월, MicrobioSeq(CD Genomics)는 바이오마커 발견 및 비항생제 치료법 개발을 지원하기 위해 '파지 전체 게놈 염기서열 분석'의 제공 개시를 발표했습니다. CD Genomics는 차세대 염기서열 분석 및 롱 리드 염기서열 분석 기술을 활용하여 바이러스 및 파지의 염기서열 분석 서비스를 제공하며, 구조 유전체학 및 비교 유전체학에 대한 심층적인 연구를 지원하고 있습니다.
본 조사의 주요 특징 :
- 이 보고서는 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장에 대해 상세히 분석하고, 2025년을 기준 연도로 하여 2026-2033년의 예측 기간 중 시장 규모 및 연평균 성장률(CAGR)을 제시하고 있습니다.
- 또한 각 부문별 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 랩온어칩 및 마이크로어레이(바이오칩) 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 '랩온어칩 및 마이크로어레이(바이오칩) 세계 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 랩온어칩 및 마이크로어레이(바이오칩) 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장
제5장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장 : 유형별, 2021-2033년
제6장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장 : 제품별, 2021-2033년
제7장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장 : 용도별, 2021-2033년
제8장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장 : 최종사용자별, 2021-2033년
제9장 세계의 랩온어칩 및 마이크로어레이(바이오칩) 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.08Lab-on-a-chip and Microarrays (Biochip) Market is estimated to be valued at USD 25,229.8 Mn in 2026 and is expected to reach USD 61,711.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 25,229.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.60% | 2033 Value Projection: | USD 61,711.4 Mn |
A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that allow many tests to be performed at the same time to achieve high throughput and speed. A biochip can complete thousands of biological reactions.
Market Dynamics:
Rise in burden of chronic diseases, rise in demand for point-of-care testing, rise in application of proteomics and genomics in cancer research, increasing adoption of personalized medicines, and rise in demand for microfluidics materials are major factors expected to augment the growth of the global lab-on-a-chip and microarrays (biochip) market.
For instance, in October 2022, MicrobioSeq (CD Genomics) announced the launch of the Phage Whole-Genome Sequencing to help discover biomarkers and to develop non-antibiotic treatment methods. CD Genomics uses next-generation sequencing and long-read sequencing technologies to provide virus or phage sequencing services and help in-depth studies of structural genomics and comparative genomics.
Key features of the study:
- The report provides in-depth analysis of the global lab-on-a-chip and microarrays (biochip) market, and provide market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2026-2033, considering 2025 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lab-on-a-chip and microarrays (biochip) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Merck KgaA, QIAGEN NV, BioMerieux, Illumina Inc., Micronit, PerkinElmer Inc., Thermo Fisher Scientific, Fluidigm Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Abbott Laboratories, Phalanx Biotech Group, and Danaher Corporation (Cepheid), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global lab-on-a-chip and microarrays (biochip) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lab-on-a-chip and microarrays (biochip) market.
Detailed Segmentation:
- Global Lab-on-a-chip and Microarrays (Biochip) Market, By Type (Revenue, USD Mn, 2021 - 2033)
- Lab-on-a-chip
- Microarray
- Global Lab-on-a-chip and Microarrays (Biochip) Market, By Product (Revenue, USD Mn, 2021 - 2033)
- Instruments
- Reagents and Consumables
- Software and Services
- Global Lab-on-a-chip and Microarrays (Biochip) Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Clinical Diagnostics
- Drug Discovery
- Genomics and Proteomics
- Other Application
- Global Lab-on-a-chip and Microarrays (Biochip) Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Biotechnology
- Pharmaceutical Companies
- Hospitals and Diagnostics Centers
- Academic and Research Institutes
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Merck KgaA
- QIAGEN NV
- BioMerieux
- Illumina Inc.
- Micronit BV
- PerkinElmer Inc.
- Thermo Fisher Scientific
- Fluidigm Corporation
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Abbott Laboratories
- Phalanx Biotech Group
- Danaher Corporation (Cepheid)
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in burden of chronic diseases worldwide
- Availability of alternative technologies
- Rise in application of proteomics and genomics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global Lab-on-a-chip and Microarrays (Biochip) Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Lab-on-a-chip
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Product, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Genomics and Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global Lab-on-a-chip and Microarrays (Biochip) Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Hospitals and Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
9. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
10. Competitive Landscape
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioMA(C)rieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Micronit BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phalanx Biotech Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Cepheid)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
